Search research articles
Contact Us
Filters
Showing results (11-20 of 54) with videos related to
Page
of 6
Sort By:
Molecular Cancer Therapeutics
|
January 9, 2003
Proof-of-principle: oncogenic beta-catenin is a valid molecular target for the development of pharmacological inhibitors
Jung-Sik Kim, Heather Crooks, Aaron Foxworth, et al.
Cancer Research
|
September 23, 2003
Transformation of mammary epithelial cells by 3-phosphoinositide- dependent protein kinase-1 activates beta-catenin and c-Myc, and down-regulates caveolin-1
Zhihui Xie, Xiao Zeng, Todd Waldman, et al.
Current Protocols in Molecular Biology
|
February 12, 2008
Human somatic cell gene targeting
Todd Waldman, Carolyn Lee, Tagvor G Nishanian, et al.
Cancer Research
|
November 1, 2008
Conspirators in a capital crime: co-deletion of p18INK4c and p16INK4a/p14ARF/p15INK4b in glioblastoma multiforme
David A Solomon, Jung-Sik Kim, Walter Jean, et al.
Cancer Biology & Therapy
|
June 16, 2004
Suppression of tumorigenesis and activation of Wnt signaling by bone morphogenetic protein 4 in human cancer cells
Tagvor G Nishanian, Jung-Sik Kim, Aaron Foxworth, et al.
Plos One
|
May 3, 2017
Correction of PTEN mutations in glioblastoma cell lines via AAV-mediated gene editing
Victoria K Hill, Jung-Sik Kim, C David James, et al.
Molecular and Cellular Biology
|
November 13, 2008
Heat shock protein Hsp72 controls oncogene-induced senescence pathways in cancer cells
Vladimir L Gabai, Julia A Yaglom, Todd Waldman, et al.
Nucleic Acids Research
|
September 12, 2008
Epitope tagging of endogenous genes in diverse human cell lines
Jung-Sik Kim, Challice Bonifant, Fred Bunz, et al.
Molecular and Cellular Biology
|
October 25, 2006
Activation of p53-dependent growth suppression in human cells by mutations in PTEN or PIK3CA
Jung-Sik Kim, Carolyn Lee, Challice L Bonifant, et al.
Cancer Research
|
May 23, 2002
Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells
Jung-Sik Kim, Heather Crooks, Tatiana Dracheva, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 54) with videos related to
Sort By:
Page
of 6
Molecular Cancer Therapeutics
|
January 9, 2003
Proof-of-principle: oncogenic beta-catenin is a valid molecular target for the development of pharmacological inhibitors
Jung-Sik Kim, Heather Crooks, Aaron Foxworth, et al.
Cancer Research
|
September 23, 2003
Transformation of mammary epithelial cells by 3-phosphoinositide- dependent protein kinase-1 activates beta-catenin and c-Myc, and down-regulates caveolin-1
Zhihui Xie, Xiao Zeng, Todd Waldman, et al.
Current Protocols in Molecular Biology
|
February 12, 2008
Human somatic cell gene targeting
Todd Waldman, Carolyn Lee, Tagvor G Nishanian, et al.
Cancer Research
|
November 1, 2008
Conspirators in a capital crime: co-deletion of p18INK4c and p16INK4a/p14ARF/p15INK4b in glioblastoma multiforme
David A Solomon, Jung-Sik Kim, Walter Jean, et al.
Cancer Biology & Therapy
|
June 16, 2004
Suppression of tumorigenesis and activation of Wnt signaling by bone morphogenetic protein 4 in human cancer cells
Tagvor G Nishanian, Jung-Sik Kim, Aaron Foxworth, et al.
Plos One
|
May 3, 2017
Correction of PTEN mutations in glioblastoma cell lines via AAV-mediated gene editing
Victoria K Hill, Jung-Sik Kim, C David James, et al.
Molecular and Cellular Biology
|
November 13, 2008
Heat shock protein Hsp72 controls oncogene-induced senescence pathways in cancer cells
Vladimir L Gabai, Julia A Yaglom, Todd Waldman, et al.
Nucleic Acids Research
|
September 12, 2008
Epitope tagging of endogenous genes in diverse human cell lines
Jung-Sik Kim, Challice Bonifant, Fred Bunz, et al.
Molecular and Cellular Biology
|
October 25, 2006
Activation of p53-dependent growth suppression in human cells by mutations in PTEN or PIK3CA
Jung-Sik Kim, Carolyn Lee, Challice L Bonifant, et al.
Cancer Research
|
May 23, 2002
Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells
Jung-Sik Kim, Heather Crooks, Tatiana Dracheva, et al.
Page
of 6